CATALIO CAPITAL MANAGEMENT
Catalio Capital Management is a Venture capital investments in breakthrough biomedical technology companies.
CATALIO CAPITAL MANAGEMENT
Industry:
Biotechnology Financial Services Venture Capital
Founded:
2016-01-01
Status:
Active
Contact:
(410) 989-6168
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible Google Font API Google Analytics Apple Mobile Web Clips Icon Google Tag Manager Google Universal Analytics Global Site Tag Google Maps Cloudflare JS
Similar Organizations
Amasia
Amasia is a thesis-driven, global venture capital firm currently focused on sustainability and climate.
Felix Capital
Felix Capital is a venture fund that focuses on digital commerce, digital media, and information technology companies.
Longitude Capital
Longitude Capital is a venture capital firm that invests in biotechnology and medical technology companies.
Rivas Capital
Rivas Capital is a private investment firm focused on long-term principal investments in breakthrough technology businesses.
Section 32
Section 32 is a venture capital fund that invests at the cutting edge of technology, healthcare, and life sciences.
Current Advisors List
Board_member
2017-06-01
Current Employees Featured
Mitchell Chan Operating Partner @ Catalio Capital Management
Operating Partner
2022-01-01
Kenan Turnacioglu General Partner @ Catalio Capital Management
General Partner
George Petrocheilos Co-Founder & Managing Partner @ Catalio Capital Management
Co-Founder & Managing Partner
2020-06-01
Jacob Vogelstein Co-Founder and Managing Partner @ Catalio Capital Management
Co-Founder and Managing Partner
2020-06-01
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-08-15 | Fractyl Health | Catalio Capital Management investment in Series F - Fractyl Health | N/A |
| 2022-07-19 | Cartography Biosciences | Catalio Capital Management investment in Series A - Cartography Biosciences | 57 M USD |
| 2022-07-13 | Xilis | Catalio Capital Management investment in Series A - Xilis | 19 M USD |
| 2022-06-08 | Anagenex | Catalio Capital Management investment in Series A - Anagenex | 30 M USD |
| 2022-05-17 | Character Biosciences | Catalio Capital Management investment in Series A - Character Biosciences | 18 M USD |
| 2022-04-28 | Octant Bio | Catalio Capital Management investment in Series B - Octant Bio | 80 M USD |
| 2022-04-26 | Pheast Therapeutics | Catalio Capital Management investment in Series A - Pheast Therapeutics | 76 M USD |
| 2022-03-24 | Celsius Therapeutics | Catalio Capital Management investment in Series B - Celsius Therapeutics | 83 M USD |
| 2022-03-22 | Affini-T Therapeutics | Catalio Capital Management investment in Venture Round - Affini-T Therapeutics | 175 M USD |
| 2022-03-15 | PrognomiQ | Catalio Capital Management investment in Venture Round - PrognomiQ | 46 M USD |
More informations about "Catalio Capital Management"
Catalio Capital Management - Crunchbase
Catalio Capital Management has led several funding rounds, including a $10 million structured equity financing for Roshal Health and a Series B financing extension for NextPoint Therapeutics. These investments indicate active …See details»
Catalio Capital Management - LinkedIn
Catalio Capital Management | 8,180 followers on LinkedIn. Full lifecycle investments in breakthrough biomedical technology companies | Catalio Capital Management was created by …See details»
Catalio Capital Management Portfolio Companies - Crunchbase
Jul 13, 2016 Catalio Capital Management is a venture capital firm that invests in breakthrough biomedical technology companies. This list of organizations invested in by Catalio Capital …See details»
Catalio Capital Management investment portfolio
Oct 8, 2024 Founded in 2020, Catalio Capital Management is a venture capital investment firm based in New York, New York. The firm prefers to invest in companies operating in the biomedical technology sector. The firm invests in …See details»
Portfolio | Catalio Capital Management
We focus on biomedical tech companies developing next-generation drugs, devices and diagnostics, and work closely with each portfolio company to build and grow the business from …See details»
Catalio Capital Management - The Org
Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or referred by Catalio Capital Management, an elite group of world-renowned, …See details»
Ben Bell | Catalio Capital Management
Benjamin Bell, Ph.D., CFA is a Senior Analyst at Catalio Capital Management, LP, focusing on public equity investments across Clinical Therapeutics. Prior to joining Catalio, Ben was a …See details»
Catalio Capital Management - Funding, Financials, Valuation
Oct 17, 2023 Catalio Capital Management has raised 1 round. This was a Private Equity round raised on Oct 17, 2023. Catalio Capital Management is funded by Kohlberg Kravis Roberts. …See details»
Catalio Capital Management | PrivSource
Catalio Capital Management is a multi-strategy investment firm specializing in breakthrough biomedical technology and healthcare innovation. Founded in 2020, the company invests in …See details»
Catalio Company Profile - Office Locations, Competitors ... - Craft
Catalio Capital Management is an investment firm that funds biomedical and life sciences firms. It invests in start-ups that develop medication, data analysis, medical devices, diagnostics, etc.See details»
Catalio Capital Management Raises Inaugural Special Situations …
Nov 7, 2022 About Catalio Capital Management. Catalio Capital Management, LP, is a multi-strategy life sciences investment firm that focuses on breakthrough biomedical technology …See details»
Catalio Capital Management | StartupHub.ai
Jun 19, 2024 Description: Catalio Capital Management was created by George Petrocheilos and Dr. Jacob Vogelstein to invest in breakthrough biomedical technology companies created or …See details»
Strategy | Catalio Capital Management
At Catalio Capital Management, we invest in breakthrough biomedical technology companies. Our founders are world-renowned, serial scientists with a proven track record in spinning out & …See details»
Catalio Capital Management launches credit strategy, hires 2 …
Feb 3, 2021 Biomedical-focused investment firm Catalio Capital Management is launching a new credit strategy that will provide non-dilutive capital to companies, and brought on a pair of …See details»
Catalio Capital Management - Contacts, Employees, Board …
Catalio Capital Management has 6 current employee profiles, including Partner and Co-Head Public Equities Ben Snedeker. Catalio Capital Management has 2 board members and …See details»
George Petrocheilos Spins Catalio Capital Management into …
Dec 24, 2020 With offices in Baltimore and Washington, DC, and now in New York, Catalio Capital Management LP is ready for the next phase of its rapid growth. John Catsimatidis Jr. …See details»
George Petrocheilos - Catalio Capital Management - LinkedIn
Founded Catalio Capital Management, a New York-based investment firm, investing… · Experience: Catalio Capital Management · Education: The Johns Hopkins University · …See details»
Catalio Capital Management LP - AUM 13F
Track the AUM, funds, and holdings for Catalio Capital Management LP over time. View the latest funds and 13F holdings. Compare against similar firms. Catalio Capital Management LP - …See details»
George C. Petrocheilos | Catalio Capital Management
George Petrocheilos is the Co-Founder and Managing Partner of Catalio Capital Management, LP. He is primarily responsible for managing the firm and for making investments in private …See details»
ARROW CAPITAL MANAGEMENT INC. LAUNCHES ANOTHER …
1 day ago For further information, please contact: Arrow Capital Management Inc., please visit www.arrow-capital.com or contact us at (416) 323-0477 / (877) 327-6048 or contact your …See details»